Cargando…

Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial

The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Kandaswamy Saravana, Asokan, Sharath, Geethapriya, PR, Sivakumar, Kailasam, Yamunadevi, Andamuthu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466600/
https://www.ncbi.nlm.nih.gov/pubmed/37654309
http://dx.doi.org/10.4103/jpbs.jpbs_579_22
_version_ 1785098921477931008
author Kumar, Kandaswamy Saravana
Asokan, Sharath
Geethapriya, PR
Sivakumar, Kailasam
Yamunadevi, Andamuthu
author_facet Kumar, Kandaswamy Saravana
Asokan, Sharath
Geethapriya, PR
Sivakumar, Kailasam
Yamunadevi, Andamuthu
author_sort Kumar, Kandaswamy Saravana
collection PubMed
description The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group.
format Online
Article
Text
id pubmed-10466600
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-104666002023-08-31 Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial Kumar, Kandaswamy Saravana Asokan, Sharath Geethapriya, PR Sivakumar, Kailasam Yamunadevi, Andamuthu J Pharm Bioallied Sci Original Article The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group. Wolters Kluwer - Medknow 2023-07 2023-07-05 /pmc/articles/PMC10466600/ /pubmed/37654309 http://dx.doi.org/10.4103/jpbs.jpbs_579_22 Text en Copyright: © 2023 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kumar, Kandaswamy Saravana
Asokan, Sharath
Geethapriya, PR
Sivakumar, Kailasam
Yamunadevi, Andamuthu
Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title_full Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title_fullStr Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title_full_unstemmed Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title_short Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
title_sort survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - a randomized controlled clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466600/
https://www.ncbi.nlm.nih.gov/pubmed/37654309
http://dx.doi.org/10.4103/jpbs.jpbs_579_22
work_keys_str_mv AT kumarkandaswamysaravana survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial
AT asokansharath survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial
AT geethapriyapr survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial
AT sivakumarkailasam survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial
AT yamunadeviandamuthu survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial